Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Tuberculosis

Study type

Observational

Funder types

Other

Identifiers

NCT00962676
4-2009-0129

Details and patient eligibility

About

For diagnosis of active tuberculosis, interferon-γ release assay based mycobacterium tuberculosis specific antigen may show higher sensitivity than tuberculin skin test in immunocompromised patients. Therefore, interferon-γ release assay have a role as a rapid diagnostic adjunctive methods for active tuberculosis in immunocompromised patients.

Enrollment

140 patients

Sex

All

Ages

20+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patient suspicious of active tuberculosis with immunocompromised condition

Immunocompromised condition patients with

  • solid cancer with chemotherapy
  • hematologic malignancy
  • organ transplantation
  • immunosuppressant
  • ESRD on renal replacement therapy
  • diabetes
  • advanced liver cirrhosis

Exclusion criteria

Patients with

  • less than 20 years
  • who don't agree the participation of study
  • hypersensitivity history to tuberculin
  • pregnancy

Trial design

140 participants in 2 patient groups

immunocompromised group
non-immunocompromised group

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems